ANI PHARMACEUTICALS INC (ANIP) Stock Analyst Earnings Estimates
NASDAQ:ANIP - Nasdaq - US00182C1036 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 316.4M 46.41% | 486.816M 53.86% | 614.376M 26.20% | 807.26M 31.40% | 866.84M 7.38% | 926.52M 6.88% | 949.12M 2.44% | 988.44M 4.14% | 1.064B 7.64% | 1.107B 4.04% | 1.149B 3.79% | |
| EBITDA YoY % growth | 30.15M 55.81% | 107.894M 257.86% | 70.568M -34.60% | 204.74M 190.13% | 228.2M 11.46% | 262.73M 15.13% | 270.3M 2.88% | 295.75M 9.42% | 250.92M -15.16% | N/A | N/A | |
| EBIT YoY % growth | -29.5M -5.73% | 48.103M 263.06% | 2.837M -94.10% | 202.77M 7,047.34% | 224.75M 10.84% | 262.55M 16.82% | 107.92M -58.90% | 135.66M 25.70% | 214M 57.75% | N/A | N/A | |
| Operating Margin | -9.32% | 9.88% | 0.46% | 25.12% | 25.93% | 28.34% | 11.37% | 13.72% | 20.11% | N/A | N/A | |
| EPS YoY % growth | 1.41 -56.75% | 4.72 234.75% | 5.20 10.17% | 6.65 27.95% | 7.22 8.48% | 8.38 16.06% | 8.62 2.90% | 9.40 9.11% | 9.96 5.86% | 10.42 4.71% | 10.86 4.21% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 1.45 42.00% | 1.56 16.56% | 1.96 20.33% | 1.52 -10.30% |
| Revenue Q2Q % growth | 194.09M 40.60% | 197.73M 33.30% | 214.28M 12.44% | 202.56M 2.76% |
| EBITDA Q2Q % growth | 44.222M -10.69% | 49.867M 102.61% | 59.916M -15.56% | 53.74M 9.48% |
| EBIT Q2Q % growth | 38.829M 92.85% | 41.212M 300.85% | 49.045M 1,422.19% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.70 40.50% | 1.41 | 0.29 | 20.55% |
| Q4 2024 Q2Q % growth | 1.63 63.00% | 1.46 | 0.17 | 11.36% |
| Q3 2024 Q2Q % growth | 1.34 5.51% | 1.11 | 0.23 | 20.97% |
| Q2 2024 Q2Q % growth | 1.02 -20.31% | 0.97 | 0.05 | 5.26% |
| Q1 2024 Q2Q % growth | 1.21 3.42% | 1.02 | 0.19 | 19.10% |
| Q4 2023 Q2Q % growth | 1.00 31.58% | 0.87 | 0.13 | 14.67% |
| Q3 2023 Q2Q % growth | 1.27 98.44% | 0.86 | 0.41 | 47.64% |
| Q2 2023 Q2Q % growth | 1.28 884.62% | 0.69 | 0.59 | 85.23% |
| Q1 2023 Q2Q % growth | 1.17 1,075.00% | 0.36 | 0.81 | 225.41% |
| Q4 2022 Q2Q % growth | 0.76 40.74% | 0.69 | 0.07 | 10.88% |
| Q3 2022 Q2Q % growth | 0.64 -36.63% | 0.56 | 0.08 | 13.57% |
| Q2 2022 Q2Q % growth | 0.13 -80.60% | 0.22 | -0.09 | -42.07% |
| Q1 2022 Q2Q % growth | -0.12 -111.54% | 0.10 | -0.22 | -226.05% |
| Q4 2021 Q2Q % growth | 0.54 -32.50% | 0.75 | -0.21 | -28.46% |
| Q3 2021 Q2Q % growth | 1.01 4.12% | 0.71 | 0.30 | 41.46% |
| Q2 2021 Q2Q % growth | 0.67 -2.90% | 0.70 | -0.03 | -4.11% |
| Q1 2021 Q2Q % growth | 1.04 | 0.72 | 0.32 | 43.61% |
| Q4 2020 Q2Q % growth | 0.80 -25.93% | 0.96 | -0.16 | -16.86% |
| Q3 2020 Q2Q % growth | 0.97 -21.14% | 0.90 | 0.07 | 7.66% |
| Q2 2020 Q2Q % growth | 0.69 -52.08% | 0.87 | -0.18 | -20.65% |
| Q1 2020 Q2Q % growth | 1.04 -20.00% | 0.91 | 0.13 | 14.56% |
| Q4 2019 Q2Q % growth | 1.08 | 1.21 | -0.13 | -10.50% |
| Q3 2019 Q2Q % growth | 1.23 | 1.46 | -0.23 | -15.63% |
| Q2 2019 Q2Q % growth | 1.44 | 1.31 | 0.13 | 9.86% |
| Q1 2019 Q2Q % growth | 1.30 | 1.07 | 0.23 | 21.77% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 197.122M 43.43% | 184.3M | 12.822M | 6.96% |
| Q4 2024 Q2Q % growth | 190.574M 44.75% | 178.87M | 11.704M | 6.54% |
| Q3 2024 Q2Q % growth | 148.332M 12.52% | 147.24M | 1.092M | 0.74% |
| Q2 2024 Q2Q % growth | 138.04M 18.44% | 131.63M | 6.41M | 4.87% |
| Q1 2024 Q2Q % growth | 137.43M 28.70% | 128.55M | 8.88M | 6.91% |
| Q4 2023 Q2Q % growth | 131.654M 39.76% | 124.65M | 7.004M | 5.62% |
| Q3 2023 Q2Q % growth | 131.829M 57.31% | 114.16M | 17.669M | 15.48% |
| Q2 2023 Q2Q % growth | 116.547M 57.71% | 100.67M | 15.877M | 15.77% |
| Q1 2023 Q2Q % growth | 106.786M 65.56% | 85.165M | 21.621M | 25.39% |
| Q4 2022 Q2Q % growth | 94.2M 54.68% | 87.862M | 6.338M | 7.21% |
| Q3 2022 Q2Q % growth | 83.8M 60.84% | 79.722M | 4.078M | 5.12% |
| Q2 2022 Q2Q % growth | 73.9M 52.06% | 73.542M | 358K | 0.49% |
| Q1 2022 Q2Q % growth | 64.5M 18.35% | 66.334M | -1.834M | -2.76% |
| Q4 2021 Q2Q % growth | 60.9M 6.28% | 57.426M | 3.474M | 6.05% |
| Q3 2021 Q2Q % growth | 52.1M -1.70% | 50.694M | 1.406M | 2.77% |
| Q2 2021 Q2Q % growth | 48.6M 0.21% | 49.011M | -411K | -0.84% |
| Q1 2021 Q2Q % growth | 54.5M 9.44% | 47.736M | 6.764M | 14.17% |
| Q4 2020 Q2Q % growth | 57.3M 19.38% | 55.352M | 1.948M | 3.52% |
| Q3 2020 Q2Q % growth | 53M 3.31% | 52.53M | 470K | 0.89% |
| Q2 2020 Q2Q % growth | 48.5M -10.85% | 47.872M | 628K | 1.31% |
| Q1 2020 Q2Q % growth | 49.8M -5.86% | 51.238M | -1.438M | -2.81% |
| Q4 2019 Q2Q % growth | 48M | 52.666M | -4.666M | -8.86% |
| Q3 2019 Q2Q % growth | 51.3M | 57.086M | -5.786M | -10.14% |
| Q2 2019 Q2Q % growth | 54.4M | 56.304M | -1.904M | -3.38% |
| Q1 2019 Q2Q % growth | 52.9M | 51.58M | 1.32M | 2.56% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.26% | -7.28% | 0% | 3.19% |
| Revenue | 1.33% | 0.97% | 0.67% | 2.91% |